Edwards Lifesciences (EW)
Health Care6 articles
Price chart
Why is EW moving today?
-1.7%EW is -1.7% today, inside the ordinary range for a session (under 3%). No stories about it reached the feed in the last 24 hours.
What this does not prove. A story on the same day is evidence of timing, not of cause: it explains a move only if it accounts for the size and the direction, and most single-stock moves carry a sector or index component too. Nothing here is a forecast.
Source: Yahoo Finance - quote as of 2 days ago
Edwards Lifesciences (EW) overview
Edwards Lifesciences specializes in heart-valve and critical-care devices.
EW is a member of the S&P 500. It sits in the Health Care sector. That sector covers pharmaceutical, biotech, device and managed-care companies.
Edwards Lifesciences trades on the NYSE under the ticker symbol EW. The most recent market data puts the share price at about $86.60. That is down 1.70% on the session. At that price the company is worth roughly $49.92B.
Over the past 52 weeks, EW has traded between $74.43 and $96.29. Shares change hands at a trailing price-to-earnings (P/E) ratio of about 51.5. The P/E ratio sets the share price against a year of earnings. A higher number means the market is paying more for each dollar the company earns.
Key statistics
Source: Yahoo Finance - quote as of 2 days ago
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch EW
EW is one of the larger names in the Health Care sector, so investors follow it closely. It tends to move with the rest of the sector. This page sums up each EW story as it breaks, and tags it bullish, bearish or neutral.
What moves EW
- Earnings. EW reports results four times a year. A surprise against the estimate tends to move the stock that day.
- Analyst calls. Upgrades, downgrades and new price targets change what the market expects from EW.
- Sector news. Health Care stocks often move together, so a rival's news can move EW too.
Market Mood
Latest EW news
Edwards Lifesciences CVP Daniel Lippis Sells $54,168 in Stock
Daniel Lippis, Chief Vice President of Edwards Lifesciences, sold $54,168 worth of stock in a recent transaction. The sale involved 1,125 shares, priced at approximately $48.10 per share. This event occurred within the framework of routine stock transactions by company insiders. Such insider trading activities can signal confidence or concerns about the company, influencing investor perceptions and market sentiment around Edwards Lifesciences (EW).
Read More: Edwards Lifesciences CVP Daniel Lippis Sells $54,168 in Stock
Edwards Lifesciences Corp (EW) Form 4 Filing on July 30
Edwards Lifesciences Corp (EW) filed a Form 4, an official statement regarding insider transactions, which is scheduled for July 30. This filing typically includes details on the buying or selling of shares by company executives or board members. Such disclosures are essential as they provide transparency regarding insider activities that may influence investor sentiment. Monitoring Form 4 filings helps investors gauge company insiders' confidence in the company’s future performance.
Read More: Edwards Lifesciences Corp (EW) Form 4 Filing on July 30
Edwards Lifesciences Corp (EW) Form 4 Filing on July 27
Edwards Lifesciences Corp (EW) has a Form 4 filing scheduled for July 27. This document will disclose changes in insider ownership, offering insights into stockholder activity. Tracking insider transactions can be essential for investors, as they may indicate expected future performance. The scheduled filing is a key event for stakeholders in the company.
Read More: Edwards Lifesciences Corp (EW) Form 4 Filing on July 27
Edwards Lifesciences CEO Sells $245,134 in Shares
Bernard Zovighian, the CEO of Edwards Lifesciences, sold shares worth $245,134. This sale may raise concerns among investors regarding insider trading patterns and confidence in the company's future performance. Shareholder reaction could influence the stock's performance following this transaction. Understanding the context of insider sales is important for investors to gauge market sentiment about Edwards Lifesciences (EW).
Read More: Edwards Lifesciences CEO Sells $245,134 in Shares
Edwards Lifesciences (EW) CFO Ullem sells $1M in company shares
Edwards Lifesciences (EW) CFO Scott Ullem sold $1 million worth of company shares. This transaction raises questions about insider sentiment regarding the company's future performance. Market reactions may follow, reflecting investor concerns or confidence based on insider trading activity. The volume of shares traded is not specified in this report.
Read More: Edwards Lifesciences (EW) CFO Ullem sells $1M in company shares
Edwards Lifesciences Trading at $83.92 with Strong Growth Prospects
As of March 16, 2026, Edwards Lifesciences Corporation's share price was $83.92, with a trailing P/E of 46.17 and a forward P/E of 28.49. The company completed a $4.2 billion divestiture of its Critical Care business, which affected approximately 20% of its 2023 EBITDA base. However, the Transcatheter Mitral and Tricuspid Therapies segment is growing over 50% year-over-year, while the Transcatheter Aortic Valve Replacement franchise generates over $4.5 billion in annual revenue with 12%+ growth. Edwards Lifesciences has a strong balance sheet, holding $3.8 billion in cash and is trading at a valuation of approximately 21.3x EV/NTM EBITDA, below its historical average of 26x.
Read More: Edwards Lifesciences Trading at $83.92 with Strong Growth ProspectsMore Health Care stocks
Frequently asked questions
Is Edwards Lifesciences in the S&P 500?
Yes. Edwards Lifesciences trades as EW and is a member of the S&P 500. The index lists it in the Health Care sector.
What sector is EW in?
EW sits in the Health Care sector of the S&P 500.
Where can I find the latest EW news?
Right here. This page collects recent EW news and market analysis. Every story gets an AI summary and a bullish, bearish or neutral tag.
What is Edwards Lifesciences's stock price?
EW last traded at about $86.60. Prices move all through the session, so this is the latest quote rather than a live one.
What is Edwards Lifesciences's market cap?
EW is worth roughly $49.92B. Market cap is the share price times the number of shares outstanding.
What is EW's P/E ratio?
EW trades at a trailing P/E ratio of about 51.5. The ratio compares the share price with earnings per share over the past year.